Recently, there are studies that up-regulation of Fancd2 expression is positively correlated with tumor size and poor prognosis in ovarian cancer, nasopharyngeal carcinoma, glioblastoma, and EC [19]. The gene discussed is FANCD2; the disease is glioblastoma.